UnitedHealth Group shares steady after mixed technicals and weak earnings outlook

Traders Union
All News
Financial News
Unitedhealth group up 0.88% today

Highlights

UnitedHealth Group (UNH) trades at $367.48, above MA-20 ($355.67) and MA-50 ($330.49), but stays below MA-200 ($393.77), indicating persistent longer-term resistance.
Q3 2025 EPS consensus for UnitedHealth is $2.84, down 60.3% year-over-year, while revenue is projected to grow 12.5% to $113.38 billion amid elevated uncertainty.
Short-term momentum for UNH remains bullish, but with RSI at 65.27 near overbought, probability of a move above $370 is under 20% and pullback risk prevails.

Profit risks highlighted as earnings estimates fall amid Medicare concerns

UnitedHealth Group is expected to report Q3 2025 earnings, with analysts projecting EPS of $2.84, a 60.3% decline year-over-year, and revenue of $113.38 billion, a 12.5% increase. The earnings estimate has seen a further downward revision in recent weeks, reflecting continued uncertainty around quarterly performance. Market attention remains on leadership changes and evolving Medicare membership risks.

Intraday bullish strength as overbought signals face oscillators’ caution

Momentum indicators show mixed but generally positive signals, with MACD signaling strong buy and ADX on D1 at a neutral 16.6 but with upside on the weekly horizon. RSI at 65.27, alongside CCI and Stoch RSI, suggests the market is close to overbought, reflected by steady bullish pressure and moderate volatility today. There was no significant gap at the open, and the current price is near the session’s high, indicating intraday strength towards the upper end of the $361.66 – $368.81 range. Intraday momentum leans toward buyers, but some oscillator divergence indicates caution is warranted, with sideways consolidation possible after the initial push.

Downside risk dominates as breakout above $370 remains unlikely

For the coming five trading days, the expected trading range is $366.16 to $370.48. The probability of a move higher is very low (less than 20%), making a decline more likely by comparison. Baseline scenario anticipates the price stabilizing between $366 and $370. If UNH breaks above $370, a bullish move could extend further, targeting higher local resistance. Conversely, a failure to hold $366 would expose it to another round of selling, retesting stronger support below $355.

Viktoras Karapetjanc, expert at Traders Union, sees UnitedHealth Group’s near-term bullish momentum supported by robust technicals and improving fundamentals, despite longer-term pressures and a sharply lower EPS outlook. He notes that while earnings uncertainty and sector headwinds remain, rising revenues and resilient sentiment help underpin confidence above $366. Karapetjanc believes that unless $366 fails, consolidation above this level is likely, positioning the stock for upside if sentiment or macro news turn more supportive. "Momentum is cautiously constructive, and as long as $366 holds, I expect stability with a potential for fresh highs on any positive news," he says.

Previously it was noted that bullish momentum diverges from overbought signals amid increased volatility in UNH shares. At that time, investors were relying on technical signals due to muted news flow and ongoing market uncertainty, as described in the discussion about bullish momentum diverges from overbought signals.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.